JPWO2019025099A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019025099A5 JPWO2019025099A5 JP2020505412A JP2020505412A JPWO2019025099A5 JP WO2019025099 A5 JPWO2019025099 A5 JP WO2019025099A5 JP 2020505412 A JP2020505412 A JP 2020505412A JP 2020505412 A JP2020505412 A JP 2020505412A JP WO2019025099 A5 JPWO2019025099 A5 JP WO2019025099A5
- Authority
- JP
- Japan
- Prior art keywords
- atoms
- nch
- unsubstituted
- alkyl
- trisubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17184272.7 | 2017-08-01 | ||
| EP17184272 | 2017-08-01 | ||
| PCT/EP2018/067797 WO2019025099A1 (en) | 2017-08-01 | 2018-07-02 | THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020528922A JP2020528922A (ja) | 2020-10-01 |
| JPWO2019025099A5 true JPWO2019025099A5 (https=) | 2022-10-04 |
| JP2020528922A5 JP2020528922A5 (https=) | 2022-10-04 |
| JP7336434B2 JP7336434B2 (ja) | 2023-08-31 |
Family
ID=59506176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505412A Active JP7336434B2 (ja) | 2017-08-01 | 2018-07-02 | アデノシン受容体アンタゴニストとしてのチアゾロピリジン誘導体 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US11186592B2 (https=) |
| EP (1) | EP3661941B1 (https=) |
| JP (1) | JP7336434B2 (https=) |
| KR (1) | KR102717280B1 (https=) |
| CN (1) | CN110997681B (https=) |
| AU (1) | AU2018309265B2 (https=) |
| CA (1) | CA3071575A1 (https=) |
| DK (1) | DK3661941T3 (https=) |
| ES (1) | ES2940407T3 (https=) |
| FI (1) | FI3661941T3 (https=) |
| HR (1) | HRP20230251T1 (https=) |
| HU (1) | HUE061308T2 (https=) |
| IL (1) | IL272284B2 (https=) |
| LT (1) | LT3661941T (https=) |
| NZ (1) | NZ760516A (https=) |
| PL (1) | PL3661941T3 (https=) |
| PT (1) | PT3661941T (https=) |
| RS (1) | RS64035B1 (https=) |
| SG (1) | SG11202000823WA (https=) |
| SI (1) | SI3661941T1 (https=) |
| TW (1) | TWI850199B (https=) |
| WO (1) | WO2019025099A1 (https=) |
| ZA (1) | ZA202001295B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR117844A1 (es) | 2019-01-22 | 2021-09-01 | Merck Patent Gmbh | Derivados de tiazolopiridina como antagonistas del receptor de adenosina |
| CN112174943A (zh) * | 2019-07-03 | 2021-01-05 | 四川大学 | 一种吲哚-2-酮类化合物在制备防治口腔细菌产品中的用途 |
| WO2022258622A1 (en) | 2021-06-07 | 2022-12-15 | Ares Trading S.A. | Combination treatment of cancer |
| KR20250048043A (ko) | 2022-08-02 | 2025-04-07 | 메르크 파텐트 게엠베하 | (S)-7-옥사-2-아자-스피로[4.5]데칸-2-카르복실산 [7-(3,6-디히드로-2H-피란-4-일)-4-메톡시-티아졸로[4,5-c]피리딘-2-일]-아미드의 신규의 결정질 형태 및 이의 공-결정 형태 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207554A (en) | 1972-08-04 | 1980-06-10 | Med-El Inc. | Method and apparatus for automated classification and analysis of cells |
| US4125828A (en) | 1972-08-04 | 1978-11-14 | Med-El Inc. | Method and apparatus for automated classification and analysis of cells |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| BR9707495A (pt) | 1996-02-13 | 1999-07-27 | Zeneca Ltd | Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente |
| US6291455B1 (en) | 1996-03-05 | 2001-09-18 | Zeneca Limited | 4-anilinoquinazoline derivatives |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| AU1688599A (en) | 1998-01-05 | 1999-07-26 | Eisai Co. Ltd. | Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| US6841549B1 (en) | 1999-07-02 | 2005-01-11 | Eisai Co., Ltd. | Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| NZ522074A (en) | 2000-05-31 | 2004-06-25 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| AU8181701A (en) * | 2000-06-21 | 2002-01-02 | Hoffmann La Roche | Benzothiazole derivatives |
| IL153484A0 (en) | 2000-07-07 | 2003-07-06 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors |
| CN1255392C (zh) | 2000-07-07 | 2006-05-10 | 安吉奥金尼药品有限公司 | 作为血管生成抑制剂的秋水仙醇衍生物 |
| WO2004089942A2 (en) | 2001-10-02 | 2004-10-21 | Acadia Pharmaceuticals Inc. | Benzimidazolidinone derivatives as muscarinic agents |
| US6713499B2 (en) * | 2001-12-12 | 2004-03-30 | Hoffman-La Roche Inc. | 7-Amino-benzothiazole derivatives |
| EP1465634B1 (en) | 2001-12-12 | 2014-10-22 | The Government of the United States of America, as represented by the Secretary Department of Health and Human Services | Methods for using adenosine receptor inhibitors to enhance immune response and inflammation |
| EP1618108A2 (en) | 2003-04-09 | 2006-01-25 | Biogen Idec MA Inc. | Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosine receptor antagonists |
| US6872833B2 (en) * | 2003-04-14 | 2005-03-29 | Hoffmann-La Roche Inc. | Adenosine receptor ligands |
| JP4444290B2 (ja) | 2003-05-19 | 2010-03-31 | エフ．ホフマン−ラ ロシュ アーゲー | アデノシン受容体リガンドとしてのベンゾチアゾール誘導体 |
| BRPI0414266A (pt) | 2003-09-19 | 2006-11-07 | Hoffmann La Roche | derivados de tiazolopiridina como ligandos receptores da adenosina |
| CN1989139B (zh) | 2004-07-22 | 2010-05-12 | 弗·哈夫曼-拉罗切有限公司 | 苯并噻唑衍生物 |
| JP5026511B2 (ja) * | 2006-05-18 | 2012-09-12 | エフ．ホフマン−ラ ロシュ アーゲー | アデノシンａ２ｂレセプターアンタゴニストとしてのチアゾロ−ピラミジン／ピリジン尿素誘導体 |
| US8168785B2 (en) * | 2009-06-17 | 2012-05-01 | Biotie Therapies, Inc. | Benzothiazole derivatives |
| GB201416754D0 (en) | 2014-09-23 | 2014-11-05 | Mission Therapeutics Ltd | Novel compounds |
-
2018
- 2018-07-02 RS RS20230195A patent/RS64035B1/sr unknown
- 2018-07-02 FI FIEP18733649.0T patent/FI3661941T3/fi active
- 2018-07-02 LT LTEPPCT/EP2018/067797T patent/LT3661941T/lt unknown
- 2018-07-02 AU AU2018309265A patent/AU2018309265B2/en active Active
- 2018-07-02 CN CN201880050465.4A patent/CN110997681B/zh active Active
- 2018-07-02 SI SI201830863T patent/SI3661941T1/sl unknown
- 2018-07-02 JP JP2020505412A patent/JP7336434B2/ja active Active
- 2018-07-02 SG SG11202000823WA patent/SG11202000823WA/en unknown
- 2018-07-02 HR HRP20230251TT patent/HRP20230251T1/hr unknown
- 2018-07-02 PT PT187336490T patent/PT3661941T/pt unknown
- 2018-07-02 PL PL18733649.0T patent/PL3661941T3/pl unknown
- 2018-07-02 KR KR1020207006084A patent/KR102717280B1/ko active Active
- 2018-07-02 CA CA3071575A patent/CA3071575A1/en active Pending
- 2018-07-02 HU HUE18733649A patent/HUE061308T2/hu unknown
- 2018-07-02 IL IL272284A patent/IL272284B2/en unknown
- 2018-07-02 US US16/635,356 patent/US11186592B2/en active Active
- 2018-07-02 ES ES18733649T patent/ES2940407T3/es active Active
- 2018-07-02 NZ NZ760516A patent/NZ760516A/en unknown
- 2018-07-02 WO PCT/EP2018/067797 patent/WO2019025099A1/en not_active Ceased
- 2018-07-02 DK DK18733649.0T patent/DK3661941T3/da active
- 2018-07-02 EP EP18733649.0A patent/EP3661941B1/en active Active
- 2018-07-31 TW TW107126410A patent/TWI850199B/zh active
-
2020
- 2020-02-28 ZA ZA2020/01295A patent/ZA202001295B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021535177A5 (https=) | ||
| RU2008134534A (ru) | 3,5-ди(арилили гетероарил)изоксазолы и 1,2,4-оксадиазолы в качестве агонистов рецентора s1p1, иммунодепрессантных и противовоспалительных агентов | |
| JP2004525117A5 (https=) | ||
| JP2020528922A5 (https=) | ||
| JP2011037841A5 (https=) | ||
| RU2003133448A (ru) | 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора | |
| JP2010511626A5 (https=) | ||
| JP2009536221A5 (https=) | ||
| JPWO2019038215A5 (https=) | ||
| JPWO2021249928A5 (https=) | ||
| JPWO2019038214A5 (https=) | ||
| JPWO2019025099A5 (https=) | ||
| JPWO2020061255A5 (https=) | ||
| JPWO2022256434A5 (https=) | ||
| JP2012519703A5 (https=) | ||
| JP2025160251A5 (https=) | ||
| RU2008131907A (ru) | Новые соединения | |
| JPWO2020051105A5 (https=) | ||
| JP2006513222A5 (https=) | ||
| JPWO2020051139A5 (https=) | ||
| JPWO2020152132A5 (https=) | ||
| JP2021532183A5 (https=) | ||
| JP2006515854A5 (https=) | ||
| JPWO2020046991A5 (https=) | ||
| JPH1081663A5 (https=) |